Malik Shahzad

CIK 00013801787 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001380178

Recent Transactions

50 trades

Award
Acutus Medical, Inc.
Common Stock
2021-06-17+1,800→ 4,022 total
Award
Acutus Medical, Inc.
Stock Options (Right to Buy)
2021-06-17+7,022→ 7,022 total
Conversion
Acutus Medical, Inc.
Series B Convertible Preferred Stock
2020-08-10−812,683→ 0 total
Conversion
Acutus Medical, Inc.
Series A Convertible Preferred Stock
2020-08-10−254,495→ 0 total
Conversion
Acutus Medical, Inc.
Common Stock
2020-08-10+1,551,713→ 1,551,713 total
Conversion
Acutus Medical, Inc.
Common Stock
2020-08-10+65,436→ 65,436 total
Conversion
Acutus Medical, Inc.
Series A Convertible Preferred Stock
2020-08-10−10,738→ 0 total
Conversion
Acutus Medical, Inc.
Series B Convertible Preferred Stock
2020-08-10−34,261→ 0 total
Conversion
Acutus Medical, Inc.
Series C Convertible Preferred Stock
2020-08-10−13,195→ 0 total
Conversion
Acutus Medical, Inc.
Series D Convertible Preferred Stock
2020-08-10−171,695→ 0 total
Conversion
Acutus Medical, Inc.
Series C Convertible Preferred Stock
2020-08-10−312,840→ 0 total
Conversion
Acutus Medical, Inc.
Series D Convertible Preferred Stock
2020-08-10−7,242→ 0 total
Award
Acutus Medical, Inc.
Common Stock
2020-08-05+2,222→ 2,222 total
Award
Acutus Medical, Inc.
Stock Options (Right to Buy)
2020-08-05+12,454→ 12,454 total
Award
Iterum Therapeutics plc$ITRM
6.500% Exchangeable Senior Subordinated Note due 2025
2020-01-21$53000.00/sh
Award
Iterum Therapeutics plc$ITRM
6.500% Exchangeable Senior Subordinated Note due 2025
2020-01-21$1495000.00/sh
Award
Aravive, Inc.
Stock Option
2019-09-12+7,500→ 7,500 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2019-06-13+19,671→ 19,671 total
Award
Aravive, Inc.
Stock Option
2019-01-03+4,688→ 4,688 total
Award
Aravive, Inc.
Stock Option
2019-01-03+4,688→ 4,688 total
Award
Axonics, Inc.
Stock Option (Right to Buy)
2018-12-06+5,000→ 5,000 total
Award
Axonics, Inc.
Common Stock
2018-12-06+2,500→ 2,500 total
Conversion
Axonics, Inc.
Common Stock
2018-11-02+404,937→ 1,694,349 total
Conversion
Axonics, Inc.
Common Stock
2018-11-02+14,412→ 1,289,412 total
Conversion
Axonics, Inc.
Series B-2 Preferred Stock
2018-11-02−36,518→ 0 total
Conversion
Axonics, Inc.
Series B-2 Preferred Stock
2018-11-02−1,025,981→ 0 total
Conversion
Axonics, Inc.
Series C Preferred Stock
2018-11-02−12,010→ 0 total
Conversion
Axonics, Inc.
Common Stock
2018-11-02+1,231,178→ 1,275,000 total
Conversion
Axonics, Inc.
Series C Preferred Stock
2018-11-02−337,447→ 0 total
Conversion
Axonics, Inc.
Common Stock
2018-11-02+43,822→ 43,822 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-1 Preferred Shares
2018-05-30−13,921→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-2 Preferred Shares
2018-05-30−218,338→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-1 Preferred Shares
2018-05-30−391,147→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+13,921→ 13,921 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30$13.00/sh+8,144→ 29,836 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30$13.00/sh+228,840→ 838,325 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-2 Preferred Shares
2018-05-30−7,771→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+7,771→ 21,692 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+391,147→ 391,147 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+218,338→ 609,485 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2018-05-24+11,241→ 11,241 total
Award
Aravive, Inc.
Common Stock
2017-12-20+11,200→ 23,880 total
Award
Aravive, Inc.
Common Stock
2017-05-25+3,480→ 12,680 total
Award
Aravive, Inc.
Stock Option (Right to Buy)
2017-05-25+6,850→ 6,850 total
Sale
Aravive, Inc.
Common Stock
2017-03-17$18.01/sh−386,367→ 1,621,558 total
Sale
Aravive, Inc.
Common Stock
2017-03-16$18.50/sh−97,303→ 2,007,925 total
Sale
Aravive, Inc.
Common Stock
2017-03-15$19.08/sh−103,122→ 2,105,228 total
Sale
Aravive, Inc.
Common Stock
2017-03-14$19.03/sh−100→ 2,255,128 total
Sale
Aravive, Inc.
Common Stock
2017-03-14$19.00/sh−46,778→ 2,208,350 total
Sale
Aravive, Inc.
Common Stock
2017-03-13$19.42/sh−16,330→ 2,255,228 total

Companies

Recent Filings

Address

C/O CONATUS PHARMACEUTICALS INC. 4365 EXECUTIVE DRIVE, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov